Drug recall · November 16, 2022
Octreotide Acetate Injection 500 mcg/mL recall
Why: Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, NDC: 67457-246-00 (syringe), 67457-246-01 (carton).
- Lots / codes
Lot #: AJ21002, Exp. 03/2024
- Quantity
- 22400 syringes
- Company
- Viatris Inc, Canonsburg, PA
- Distribution
- Nationwide in the USA
- Initiated
- October 7, 2022 · Voluntary: Firm initiated
- Classified
- November 8, 2022
- Reported
- November 16, 2022
- Ended
- January 12, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Octreotide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.